Gardasil® 9 (HPV 9-valent vaccine, recombinant) – Expanded indication
October 5, 2018 - The FDA announced the approval of Merck’s Gardasil 9 (Human Papillomavirus [HPV] 9-valent vaccine, recombinant), for use in males and females aged 9 through 45 years, for the prevention of certain cancers and diseases caused by nine HPV types.
Top